What is a stock summary page? Click here for an overview.
Business Description
Silexion Therapeutics Corp
ISIN : KYG1281K1067
Description
Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.26 | |||||
| Equity-to-Asset | -1.39 | |||||
| Debt-to-Equity | -1.13 | |||||
| Debt-to-EBITDA | -0.27 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate Estimate | 55.31 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.51 | |||||
| 9-Day RSI | 33.91 | |||||
| 14-Day RSI | 40.73 | |||||
| 3-1 Month Momentum % | -51.16 | |||||
| 6-1 Month Momentum % | -78.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.64 | |||||
| Quick Ratio | 0.64 | |||||
| Cash Ratio | 0.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -62.36 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -474.79 | |||||
| ROIC % | -1050.67 | |||||
| ROC (Joel Greenblatt) % | -6705.17 | |||||
| ROCE % | -2238.07 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.72 | |||||
| EV-to-Forward-EBIT | -0.8 | |||||
| EV-to-EBITDA | -0.72 | |||||
| EV-to-FCF | -1.42 | |||||
| Earnings Yield (Greenblatt) % | -138.89 | |||||
| FCF Yield % | -103.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SLXN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Silexion Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -22.356 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 40.73 | ||
| 14-Day ATR ($) | 0.147024 | ||
| 20-Day SMA ($) | 1.1991 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.575 - 41.85 | ||
| Shares Outstanding (Mil) | 8.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Silexion Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Silexion Therapeutics Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Silexion Therapeutics Corp Frequently Asked Questions
What is Silexion Therapeutics Corp(SLXN)'s stock price today?
The current price of SLXN is $0.94. The 52 week high of SLXN is $41.85 and 52 week low is $0.57.
When is next earnings date of Silexion Therapeutics Corp(SLXN)?
The next earnings date of Silexion Therapeutics Corp(SLXN) is .
Does Silexion Therapeutics Corp(SLXN) pay dividends? If so, how much?
Silexion Therapeutics Corp(SLXN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers